絞り込み

16644

広告

「"Hendifar AE "[Author]」の検索結果

23件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Raynaud's Phenomenon From PD-1 Immune Checkpoint Inhibition.

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations.

An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol.

Current Practices and Novel Techniques in the Diagnosis and Management of Neuroendocrine Tumors of Unknown Primary.

Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden.

Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms.

Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patients.

Multi-omic molecular comparison of primary versus metastatic pancreatic tumours.

Methylated plasma test for colorectal cancer detection may be applicable to Lynch syndrome.

Pancreatic cancer 'mismatch' in Lynch syndrome.

Evidence-Based Policy in Practice: Management of Carcinoid Syndrome Diarrhea.

Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data.

Stromal Hyaluronan Accumulation is Associated with Low Tumor Grade and Nodal Metastases in Pancreatic Ductal Adenocarcinoma.

Pancreas Cancer-Associated Weight Loss.

Cardiac Toxicity in a Patient Receiving Peptide Receptor Radionuclide Therapy.

The Evolving Treatment Algorithm for Advanced Neuroendocrine Neoplasms: Diversity and Commonalities Across Tumor Types.

Utility of Endoscopic Ultrasound-Guided Biopsy for Next-Generation Sequencing of Pancreatic Exocrine Malignancies.

Molecular Profiling of Pancreatic Cancer Patients: Initial Results from the Know Your Tumor Initiative.

Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination.

Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy.

  1. 1
  2. 2
  3. 3
Sort by
※並べ替えは表示に時間がかかります